1 0

    FDA Patent Form 3542 for NDA 213674 – Xtandi (Enzalutamide) US Patent 12,161,628

    FDA Patent Form 3542 for NDA 213674 – Xtandi (Enzalutamide) US Patent 12,161,628

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: I would like to request the Form "3542” for the US 12,161,628 for NDA #213674; Xtandi (Enzalutamide) oral tablet, (NDA holder – Astellas Pharma US INC).
    Tags: Pharma, NDA, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details